Mytide Therapeutics
Jason Norris has been working in the industry since 2005, when they began their role as Managing Director Structured Finance at The Bernstein Companies. In 2016, they cofounded Elektrofi, and then in 2018, they cofounded mytide therapeutics. In 2021, they became a Cofounder of LAPIX Therapeutics. In addition to their professional roles, Jason Norris is also a Member of YPO, a position they have held since 2015.
Jason Norris holds a Master of Business Administration (MBA) from the Massachusetts Institute of Technology and an Economics degree with Honors from the University of North Carolina at Chapel Hill.
This person is not in any teams
Mytide Therapeutics
Mytide is a tech-enabled biotechnology manufacturing services company focused on the production of peptides for drug discovery and development. Mytide's mission is to provide rapid access to high-quality peptides through its innovative ecosystem, which includes a rapid turn-around peptide membership services program.